Role of Peripheral 5-hydroxytryptamine in Toll-like Receptor 4-mediated Diabetes Mellitus Type 2
10.16476/j.pibb.2024.0520
- VernacularTitle:外周5-羟色胺在Toll样受体4介导的2型糖尿病中的作用
- Author:
Yi-Ying ZHANG
1
;
Ping ZHANG
1
;
Bo YANG
1
;
Xiao-Tong CHANG
1
Author Information
1. Medical Laboratory College, Hebei North University, Zhangjiakou 075000, China
- Publication Type:Journal Article
- Keywords:
diabetes mellitus type 2;
Toll-like receptor 4;
5-hydroxytryptamine
- From:
Progress in Biochemistry and Biophysics
2025;52(5):1070-1080
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, the prevalence of diabetes has continued to rise, with diabetes mellitus type 2 (T2DM) being the most common form. T2DM is characterized by chronic low-grade inflammation and disruptions in insulin metabolism. Toll-like receptor 4 (TLR4) is a key pattern recognition receptor that, upon activation, upregulates pro-inflammatory cytokines via the nuclear factor κB (NF‑κB) pathway, thereby contributing to the pathogenesis of T2DM. Peripheral 5-hydroxytryptamine (5-HT), primarily synthesized by enterochromaffin (EC) cells in the gut, interacts with 5-hydroxytryptamine receptors (5-HTRs) in key insulin-target tissues, including the liver, adipose tissue, and skeletal muscle. This interaction influences hepatic gluconeogenesis, fat mobilization, and the browning of white adipose tissue. Elevated peripheral 5-HT levels may disrupt glucose and lipid metabolism, thereby contributing to the onset and progression of T2DM. Within mitochondria, 5-HT undergoes degradation and inactivation through the enzymatic action of monoamine oxidase A (MAO-A), leading to the generation of reactive oxygen species (ROS). Excessive ROS production and accumulation can induce oxidative stress, which may further contribute to the pathogenesis of T2DM. Platelets serve as the primary reservoir for5-HT in the bloodstream. The activation of the TLR4 signaling pathway on the platelet surface, coupled with reduced expression of the 5-HT transporter on the cell membrane, leads to elevated serum 5-HT levels, potentially accelerating the progression of T2DM. Therefore, inhibition of TLR4 and reduction of peripheral 5-HT levels could represent promising therapeutic strategies for T2DM. This review explores the synthesis, transport, and metabolism of peripheral 5-HT, as well as its role in TLR4-mediated T2DM, with the aim of providing novel insights into the clinical diagnosis, treatment, and evaluation of T2DM.
